Peter Jay
Adult Reconstructive Orthopaedic Surgery · Baltimore, MDNPI 1891783114
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 39.4% of the total. Reporting peaked in 2019 at $59 and has fallen 62.3% since, to $22 in 2023. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in MD, where the typical reported total is $10,251.
Across 5 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$45
- Si-bone, Inc.$31
- Amgen$28
- Fidia Pharma USA Inc.$10
What the payments were for
- Food & beverage$114100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 2 | $45 |
| Si-bone, Inc. | 1 | $31 |
| Amgen | 1 | $28 |
| Fidia Pharma USA Inc. | 1 | $10 |
How this compares
$114 in reported general payments places this provider in the 5th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.
See all adult reconstructive orthopaedic surgery providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 48 | $1,400 |
| Meloxicam | 132 | $581 |
| Ondansetron OdtOndansetron | 51 | $437 |
| Prednisone | 139 | $219 |
| Methylprednisolone | 16 | $84 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Baltimore
- Michael MontBaltimore$10.9M
- Pablo WagnerBaltimore$118K
- James NaceBaltimore$102K
- Mark HasenauerBaltimore$35K
- Gregory MendezBaltimore$10K
- Marissa BonyunBaltimore$8K
- Grant DuvallBaltimore$3K
- Robert McKinstryBaltimore$1K
- Randal LewisChevy Chase$2.6M
- Sridhar DurbhakulaBethesda$766K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.